45 related articles for article (PubMed ID: 17918142)
1. Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy.
Katsarou M; Stratikos E; Chroni A
J Lipid Res; 2018 Dec; 59(12):2339-2348. PubMed ID: 30309894
[TBL] [Abstract][Full Text] [Related]
2. A case report of youth-onset lipoprotein glomerulopathy with APOE Chicago mutation.
Liu Y; Cheng Y; Wen Y; Li C; Chen G; Li M
BMC Nephrol; 2024 Mar; 25(1):87. PubMed ID: 38448817
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report.
Kato J; Okonogi H; Kanzaki G; Katsumata H; Nakada Y; Sagasaki M; Komine K; Ito K; Saito T; Matsunaga A; Tokutou K; Honda K; Tsuboi N; Yokoo T
BMC Nephrol; 2024 May; 25(1):171. PubMed ID: 38769490
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E-associated Lipoprotein Glomerulo-tubulopathy.
Tanimizu H; Hara R; Sekine A; Inoue N; Hasegawa E; Tanaka K; Kono K; Kinowaki K; Ohashi K; Okubo M; Yamaguchi Y; Kang D; Honda K; Saito T; Sawa N; Ubara Y; Hoshino J
Intern Med; 2023; 62(15):2209-2214. PubMed ID: 37532513
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein glomerulopathy: a rare cause of steroid-resistant nephrotic syndrome in a child.
Vala K; Shah K; Kapadia S; Khandelwal M; Jojera A; Soni S; Prajapati A; Saha A
CEN Case Rep; 2024 Mar; ():. PubMed ID: 38438730
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy.
Qin Y; Sun XJ; Hu YF; Jing M; Yu XJ; Zhao MH; Tan Y
Ren Fail; 2024 Dec; 46(1):2332491. PubMed ID: 38584145
[TBL] [Abstract][Full Text] [Related]
7. An Updated Review and Meta Analysis of Lipoprotein Glomerulopathy.
Li MS; Li Y; Liu Y; Zhou XJ; Zhang H
Front Med (Lausanne); 2022; 9():905007. PubMed ID: 35602473
[TBL] [Abstract][Full Text] [Related]
8. A case of lipoprotein glomerulopathy in a Greek Caucasian male.
Marinaki S; Kalaitzakis E; Kolovou K; Gakiopoulou H; Stylianou K; Papasotiriou M; Boletis IN
Int Urol Nephrol; 2022 Apr; 54(4):969-970. PubMed ID: 34160779
[No Abstract] [Full Text] [Related]
9. Lipoprotein Glomerulopathy in a Hispanic Female: A Case Report and Literature Review.
Majeed NK; McLaughlin J; Gonzalez M
Can J Kidney Health Dis; 2019; 6():2054358119859576. PubMed ID: 31285830
[TBL] [Abstract][Full Text] [Related]
10. A novel apolipoprotein E mutation (p.Arg150Cys) in a Chinese patient with lipoprotein glomerulopathy.
Ku M; Tao C; Zhou AA; Cheng Y; Wan QJ
Chin Med J (Engl); 2019 Jan; 132(2):237-239. PubMed ID: 30614865
[No Abstract] [Full Text] [Related]
11. Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: A review.
Cambruzzi E; Pêgas KL
J Bras Nefrol; 2019; 41(3):393-399. PubMed ID: 30421781
[TBL] [Abstract][Full Text] [Related]
12. Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.
Luo B; Huang F; Liu Q; Li X; Chen W; Zhou SF; Yu X
Am J Nephrol; 2008; 28(2):347-53. PubMed ID: 18046082
[TBL] [Abstract][Full Text] [Related]
13. A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy.
Chen S; Liu ZH; Zheng JM; Zhang X; Li LS
J Nephrol; 2007; 20(5):568-75. PubMed ID: 17918142
[TBL] [Abstract][Full Text] [Related]
14. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
[TBL] [Abstract][Full Text] [Related]
15. Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy.
Konishi K; Saruta T; Kuramochi S; Oikawa S; Saito T; Han H; Matsunaga A; Sasaki J
Nephron; 1999; 83(3):214-8. PubMed ID: 10529627
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.
Chang CF; Lin CC; Chen JY; Yang AH; Shiao MS; Kao JT; Yang WC
Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707
[TBL] [Abstract][Full Text] [Related]
17. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.
Saito T; Ishigaki Y; Oikawa S; Yamamoto TT
Trends Cardiovasc Med; 2002 Feb; 12(2):67-70. PubMed ID: 11852253
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein glomerulopathy in China.
Chen Y
Clin Exp Nephrol; 2014 Apr; 18(2):218-9. PubMed ID: 24165683
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
